These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9365575)

  • 1. Cyclosporine A reduction and withdrawal in liver transplantation: a risk-benefit analysis.
    Golling M; Frankenberg MV; Hofmann WJ; Lohse A; Herfarth C; Otto G
    Transplant Proc; 1997 Nov; 29(7):2819-21. PubMed ID: 9365575
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.
    Abouljoud MS; Levy MF; Klintmalm GB
    Transplant Proc; 1995 Feb; 27(1):1121-3. PubMed ID: 7533360
    [No Abstract]   [Full Text] [Related]  

  • 3. Maintenance immunosuppression using cyclosporine monotherapy in adult orthotopic liver transplant recipients.
    Tchervenkov JI; Tector AJ; Cantarovich M; Tahta SA; Asfar A; Naimi J; Elias N; Barkun J
    Transplant Proc; 1996 Aug; 28(4):2247-9. PubMed ID: 8769214
    [No Abstract]   [Full Text] [Related]  

  • 4. Transient hyperphosphatasemia after liver transplantation in infancy.
    Lachaux A; Chambon M; Boillot O; Le Gall C; Loras I; Canterino I; Pouillaude JM; Gille D; David L; Hermier M
    Transplant Proc; 1996 Oct; 28(5):2847. PubMed ID: 8908095
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful conversion from cyclosporine to tacrolimus for immunosuppression.
    Sekido H; Takeda K; Morioka D; Kubota T; Togo S; Nakatani Y; Matsunami H; Lynch SV; Strong RW; Shimada H
    Transplant Proc; 2000 Nov; 32(7):2120-2. PubMed ID: 11120096
    [No Abstract]   [Full Text] [Related]  

  • 6. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
    Levy GA
    Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
    [No Abstract]   [Full Text] [Related]  

  • 7. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
    Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
    Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of anti-rejection therapy by serum bile acids after liver transplantation.
    Klar E; Theilmann L; Hoffmann V; Hofmann W; Kraus T; Mehrabi A; Herfarth C
    Transplant Proc; 1998 Nov; 30(7):3567-9. PubMed ID: 9838562
    [No Abstract]   [Full Text] [Related]  

  • 9. Strategy for chronic rejection in recipient of living-related liver transplantation.
    Koyamada N; Ohkohchi N; Doi H; Orii T; Kikuchi H; Chubachi S; Sekiguchi S; Kawagishi N; Haga I; Nakajima N; Satomi S; Oguma S
    Transplant Proc; 2000 Nov; 32(7):2134-6. PubMed ID: 11120102
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.
    Baruch Y; Assy N; Kramsky R; Enat R
    Transplant Proc; 1998 Aug; 30(5):1852-3. PubMed ID: 9723306
    [No Abstract]   [Full Text] [Related]  

  • 11. Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients.
    Gómez R; Moreno E; Colina F; Loinaz C; Gonzalez-Pinto I; Lumbreras C; Perez-Cerdá F; Castellón C; García I
    J Hepatol; 1998 Jan; 28(1):150-6. PubMed ID: 9537852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.
    Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
    Transplant Proc; 1998 Aug; 30(5):1830-2. PubMed ID: 9723299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo hepatitis B virus infection after orthotopic liver transplantation.
    Liu PP; Chen CL; Chen YS; Tai DI
    Transplant Proc; 1996 Jun; 28(3):1684-6. PubMed ID: 8658839
    [No Abstract]   [Full Text] [Related]  

  • 14. Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation.
    Grasser B; Iberer F; Schaffellner S; Kniepeiss D; Stauber R; Koshsorur G; Rehak P; Tscheliessnigg KH
    Transplant Proc; 2001 May; 33(3):2154-6. PubMed ID: 11377484
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with neoral cyclosporine through the oral route in liver transplantation.
    Bilbao I; Lazaro JL; Pou L; Charco R; Hildalgo E; Murio E; Margarit C
    Transplant Proc; 1998 Jun; 30(4):1432-4. PubMed ID: 9636580
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine Neoral in renal transplant recipients: impact on hepatic dysfunction.
    Bakr MA; Refaie A; Mekresh M; Ihab MH; Sobh M; Ghoneim MA
    Transplant Proc; 1997 Nov; 29(7):2939-40. PubMed ID: 9365621
    [No Abstract]   [Full Text] [Related]  

  • 17. Significance of mycophenolate mofetil treatment in patients with HCV reinfection after liver transplantation: impact on clinical course and histologic damage.
    Bahra M; Neumann UP; Harren M; Jacob D; Langrehr JM; Berg T; Neuhaus R; Neuhaus P
    Transplant Proc; 2002 Nov; 34(7):2934-5. PubMed ID: 12431663
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation.
    Gozzo ML; Avolio AW; Colacicco L; Agnes S; Forni F; Barbaresi G; Castagneto M
    Transplant Proc; 1993 Apr; 25(2):1760-1. PubMed ID: 8097065
    [No Abstract]   [Full Text] [Related]  

  • 19. Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.
    Rabkin JM; Rosen HR; Corless CL; Olyaei AJ
    Transplant Proc; 2002 Aug; 34(5):1557-8. PubMed ID: 12176483
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-containment strategies in transplantation: the utility of cyclosporine-ketoconazole combination therapy.
    Odocha O; Kelly B; Trimble S; Murigande C; Toussaint RM; Callender CO
    Transplant Proc; 1996 Apr; 28(2):907-9. PubMed ID: 8623456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.